Rheumatology Rundown: Vaccinations in JIA; RA and T2D; SLE Quality of Life
The latest news in rheumatology includes the need for robust vaccinations in juvenile idiopathic arthritis; new findings about rheumatoid arthritis (RA) and type 2 diabetes; and quality of life in systemic lupus erythematosus.
Lower Vaccine Antibody Levels Seen in Juvenile Idiopathic Arthritis
A recent study of children with juvenile idiopathic arthritis (JIA) illustrates the pressing need for continued routine vaccinations. A report in
The study found that protective levels of antibodies for those with incomplete vaccinations ranged from 50% for hepatitis B, 52% for diphtheria, 58% for measles, 80% for mumps, and 98% for rubella.
Fifty patients did not achieve a complete vaccine dosing schedule against MMR. Among those, 39% were treated with biologics, 22% with methotrexate, and 14% with nonsteroidal anti-inflammatory drugs.
When comparing patients with complete and incomplete vaccinations, those with incomplete status had a lower level of antibodies against mumps and diphtheria; treatment with methotrexate and biologics were strong indicators of diphtheria revaccination omission. Incomplete vaccination was also a risk factor for nonprotective levels of antibodies against measles.
Study Highlights Need for Cardiovascular Disease Prevention in RA, T2D
In patients with rheumatoid arthritis (RA) with type 2 diabetes (T2D), the use of cardiovascular disease (CVD) medication and prevalence of atherosclerotic cardiovascular disease (ASCVD) were doubled compared with patients with RA who did not have T2D, according to a
Both RA and T2D are historically associated with increased risk of ASCVD. The
Patients With Lupus, Cardiovascular Autonomic Neuropathy Report Lower QOL
Patients with systemic lupus erythematosus (SLE) had more self-reported cardiovascular autonomic neuropathy, along with impaired health-related quality of life (QOL) and parasympathetic function, when compared with a control group that had cardiovascular autonomic neuropathy but not SLE, according to a report published in
The relationship of autonomic dysfunction as it relates to QOL has been studied in other diseases but not in SLE, the report said.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025
- Modest Reductions in PrEP Coverage Result in Avoidable HIV Infections
September 17th 2025